Third dose of COVID-19 vaccine approved for immunocompromised over 12
October 6, 2021Research and Development
The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …
Merck secures Singapore deal for COVID antiviral pill
October 6, 2021Medical Communications, Research and Development
Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …
Bayer wins first court case in Roundup child cancer battle
October 6, 2021Medical Communications, Research and Development
Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …
Transgene and BioInvent to present oncolytic virus data at SITC 2021
October 5, 2021Manufacturing and Production
Biotech companies Transgene and BioInvent International AB (BioInvent), have announced that they will present preclinical data on their novel dual …
AstraZeneca requests emergency authorisation for COVID-19 drug
October 5, 2021Manufacturing and Production
AstraZeneca has submitted an FDA request for Emergency Use Authorisation (EUA) for AZD7442, a long-acting antibody combination (LAAB) for the …
Kintor begins Phase III trial of proxalutamide for COVID patients in US
October 5, 2021Manufacturing and Production
Chinese clinical-stage drug developer, Kintor Pharmaceutical Ltd, has announced the initiation of the Phase III clinical trial of proxalutamide for …
Brain implant can lift severe depression, study finds
October 5, 2021Manufacturing and Production, Research and Development
Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …
NICE recommends first new sickle cell disease treatment in 20 years
October 5, 2021Manufacturing and Production, Medical Communications, Research and Development
NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …
AlzeCure’s Alzheimer project initiates Phase I study
October 4, 2021Sales and Marketing
Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending …
SEED invests in CBD brand business
October 4, 2021Sales and Marketing
SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand …
Bayer Phase III trial results prove positive for diabetes patients
October 4, 2021Sales and Marketing
Bayer has revealed positive results from their FIGARO-DKD Phase III trial of Kerendia (finerenone), which showcased the drug’s ability to …
Eli Lilly and India’s Cipla enter deal on diabetes treatments
October 4, 2021Business Services, Sales and Marketing
Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling …
FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu
October 4, 2021Research and Development, Sales and Marketing
AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …
Faron raises over €10mln to support key drug candidates
October 1, 2021Medical Communications
Clinical stage biopharmaceutical company, Faron, has raised €10.5mln through a placing of new shares backed by the European Innovation Council …
Delta variant found to be common in children across US
October 1, 2021Medical Communications
School-aged children across the US are being exposed to the increasingly prevalent Delta variant of COVID-19. This is linked to …
New Gyros kit supports cell and gene therapy
October 1, 2021Medical Communications
Gyros Protein Technologies, leading provider of peptide synthesisers and reagents, has introduced the Gyrolab® AAV9 Titer Kit to support AAV-based …
Takeda: Stainless steel COVID vaccine contamination due to human error
October 1, 2021Medical Communications
Takeda has said that “human error” led to metal contaminants being present in Moderna’s COVID-19 vaccine doses, which caused around …
GSK and Merck KGaA end collaboration on cancer drug hopeful
October 1, 2021Medical Communications
GSK and German based Merck KGaA announced on Thursday that they have ended their collaboration on cancer treatment bintrafusp alfa, …
EADV reveals vaccine hesitancy in psoriasis patients
September 30, 2021Business Services
Research presented at the European Academy of Dermatology and Venerology (EADV) 30th Congress has revealed that psoriasis and psoriatic arthritic …
Nanoform granted funding to tackle global health challenges
September 30, 2021Business Services
Innovative nanoparticle medicine company, Nanoform, has announced that proof of concept studies will receive funding from the Bill & Melinda …
Latest content
